A Narrative Review of Impact of Incentive Spirometer Respiratory Training in Long COVID
Yao-Hsiang Chen,Yu-Shan Hsieh
DOI: https://doi.org/10.2147/ijgm.s492772
IF: 2.145
2024-11-16
International Journal of General Medicine
Abstract:Yao-Hsiang Chen, 1, 2 Yu-Shan Hsieh 2 1 Department of Nursing, Tri-Service General Hospital Songshan Branch, Taipei City, Taiwan; 2 School of Nursing, National Taipei University of Nursing and Health Sciences, Taipei City, Taiwan Correspondence: Yu-Shan Hsieh, National Taipei University of Nursing and Health Sciences, No. 365, Ming-te Road, Peitou Dist, Taipei City, 112303, Taiwan, Tel +886-2-28227101, Email Long COVID refers to symptoms that appear 3 months after initial infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of Coronavirus disease 2019 (COVID-19), and last for at least 2 months, not attributable to other diagnoses. This health issue significantly burdens patients' quality of life, the economy, and society. Improving the af-termath of COVID-19 is a crucial global health issue in the post-pandemic era. According to current results, it is evident that developing a simple, low-cost respiratory training method that can be easily used at home by themselves with long Coronavirus disease 2019 symptoms (long COVID) is an important and urgent issue. The incentive spirometer is widely used in physical, speech, and respiratory therapy, as well as in preventing postoperative pulmonary infections and improving sputum clearance. However, to date, the role of incentive spirometer respiratory training in long COVID symptoms is still limited. In this literature review is presented to explore the effectiveness of incentive spirometer respiratory training in alleviating symptoms among individuals recovering from long COVID. We also compile non-invasive assessment methods, with the aim to enable individuals to undergo training and assessments conveniently at home or in the community. In this review, a literature review approach was utilized to explore the effectiveness of incentive spirometer intervention in alleviating long-term COVID symptoms. This study is to synthesize the findings of articles published during January 2019 and December 2023 retrieved from PubMed/CINAHL/MEDLINE/ Google Scholar without re-strictions on study type. We ultimately identified seven articles and have summarized similar past studies. This review could contribute to improving symptoms related to long COVID by incentive spirometer respiratory training and serve as practical reference material for clinical medical staff and provide insights for healthcare policymakers in de-veloping guidelines for future research directions, clinical guidance, and educational strategies in the context of nursing care. Keywords: COVID-19, long COVID, incentive spirometer respiratory training, respiratory training, incentive Spirometer The coronavirus disease (COVID-19) pandemic, the most significant public health crisis of the 21st century, has rapidly spread worldwide, with more than 7.8 billion confirmed cases by the end of July 2024. In Taiwan, 140.9 million confirmed cases have occurred, as well as instances of reinfection. 1 After Taiwan's COVID-19 expenses were reclassified under the National Health Insurance coverage on March 20, 2023 within just nine months, the expenditure on Western medicine primary care for addressing post-COVID care increased by 0.3 million USD, and hospital medical expenses increased by 10.3 million USD. 2 In the United Kingdom, statistics indicate that the cost of primary healthcare services within 12 weeks post-COVID-19 infection is approximately £2.44 to £5.72 (3.17 to 7.43 US dollar) per person. Within a year, patients who had contracted COVID-19 experienced a 22.7% increase in primary healthcare consultations. The national cost for primary healthcare consultations to support long-term COVID-19 patients is estimated to be around £23 million, but it could approach £60 million, 3 another statistics from the United States show that the monthly medical expenses increase by an additional $223.60 following a diagnosis of COVID-19. 4 It is evident that the cost incurred by countries for post-treatment of COVID-19 is extremely substantial. However, challenges persist with the emergence of long-term complications associated with COVID-19, termed "long COVID" by the World Health Organization (WHO). Long COVID refers to symptoms that appear 3 months after initial infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of COVID-19, and last for at least 2 months, not attributable to other diagnoses. Long COVID has a chronic impact on multiple organ systems, with symptoms including fatigue, cognitive impairment, chest tightness, palpitations, respiratory difficulties, and depression. 5 Statistics from 2021 indicate that up to 80% of individuals experience symptoms related to long COVID, with less than 1% achieving complete recovery within 80 -Abstract Truncated-
medicine, general & internal